Search results

Technologies 1

• Implantable cancer vaccine
  The Wyss Institute’s implantable, biodegradable cancer vaccine leverages immunotherapeutic methods and could one day help overcome melanoma, other cancers, infectious diseases, auto-immune diseases, as well as vaccinate against specific peptides, proteins, or antigens. The implant is a biodegradable polymer scaffold containing growth factors and components of each patient’s tumors. The technology was initially designed to...

News 5

View all

• Research Spotlights Harnessing Nature to Beat Cancer
  February 28, 2019
• Translation News Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
  March 20, 2018
• Press Release Personal cancer vaccines get their own boost
  March 5, 2018